Juno Therapeutics Rebound Will Continue, Vetr Crowd Says

By: via Benzinga
2016 wasn't especially kind to Juno Therapeutics Inc (NASDAQ: JUNO) stock. Shares of the small cap biopharmaceutical have lost ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.